J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.

A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.

J. Enz. Inh. Med. Chem. 2008, 23(5), 728-738.

N-Pyridinyl(methyl)-indole-1- or 3-propanamides and propenamides acting as topical and systemic anti-inflammatory inhibitors.

Eur. J. Med. Chem., 2007, 42(5), 686-693.

Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents.

Eur. J. Immunol. 2005, 35, 546-56. 

A new  carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturation.

Med. Chem. Lett. 2004, 14, 5441-5444.

New N-pyridinyl(methyl)-indolalkanamides acting as topical inflammation inhibitors. Bioorg.

J. Enz. Inh. Med. Chem. 2003, 18, 201-208.

New N-pyridinyl (methyl) N1-substituted-3-indolylpropanamides acting as topical and systemic inflammation inhibitors.

J. Enz. Inh. Med. Chem. 2002, 17, 415-424.

New N-pyridinyl(methyl)indole-2 and 3-(alkyl)carboxamides and derivatives acting as systemic and topical inflammation inhibitors.

Eur. J. Pharmacol. 2001, 431, 103-110.

Effects of tumour necrosis factor-a synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis.

 Eur. J. Med. Chem. 2001, 36, 639-649.

New antiinflammatory N-pyridinyl(alkyl)phtalimides acting as tumor necrosis factor-a production inhibitors. 

Eur. J. Med. Chem. 2001, 36, 545-553.

N-Pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors. 

J. Pharm. Pharmacol. 2001, 53, 417-423.

Synthesis of N-pyridinyl(methyl)-1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carbo-xamides and analogues and their anti-inflammatory activity in mice and rats.

Pharm. Pharmacol. Commun. 1999, 5, 233-238.

N-Pyridinyl(alkyl)polyhalogenobenzamides acting as TNF-a production inhibitors.